Alphamab Oncology (HKG:9966)
6.25
-0.10 (-1.50%)
Nov 10, 2026, 4:08 PM HKT
| Market Cap | 6.05B -34.1% |
| Revenue (ttm) | 598.06M -34.1% |
| Net Income | -203.16M |
| EPS | -0.21 |
| Shares Out | 968.51M |
| PE Ratio | n/a |
| Forward PE | 28.40 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 589,000 |
| Open | 6.26 |
| Previous Close | 6.34 |
| Day's Range | 6.20 - 6.44 |
| 52-Week Range | 5.87 - 12.20 |
| Beta | 0.69 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 27, 2026 |